Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Purchases 64,461 Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA)

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 24.0% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 333,416 shares of the pharmacy operator’s stock after buying an additional 64,461 shares during the quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Walgreens Boots Alliance were worth $15,254,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Caisse DE Depot ET Placement DU Quebec increased its stake in Walgreens Boots Alliance by 1.8% in the 4th quarter. Caisse DE Depot ET Placement DU Quebec now owns 14,484,065 shares of the pharmacy operator’s stock valued at $853,980,000 after buying an additional 257,400 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Walgreens Boots Alliance by 1.9% in the fourth quarter. Geode Capital Management LLC now owns 11,207,142 shares of the pharmacy operator’s stock valued at $659,354,000 after buying an additional 205,271 shares during the last quarter. Norges Bank bought a new position in shares of Walgreens Boots Alliance during the 4th quarter worth approximately $492,928,000. American International Group Inc. increased its holdings in shares of Walgreens Boots Alliance by 781.9% during the 4th quarter. American International Group Inc. now owns 5,511,875 shares of the pharmacy operator’s stock worth $324,980,000 after acquiring an additional 4,886,896 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in Walgreens Boots Alliance by 3.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,959,827 shares of the pharmacy operator’s stock valued at $233,472,000 after acquiring an additional 134,674 shares during the period. Hedge funds and other institutional investors own 58.03% of the company’s stock.

Walgreens Boots Alliance stock traded down $0.15 during mid-day trading on Friday, reaching $39.60. 3,378,765 shares of the company were exchanged, compared to its average volume of 7,383,946. The firm has a market cap of $34.87 billion, a PE ratio of 6.87, a PEG ratio of 1.83 and a beta of 0.55. The company has a debt-to-equity ratio of 1.34, a current ratio of 0.66 and a quick ratio of 0.32. The company has a fifty day simple moving average of $42.22 and a 200-day simple moving average of $51.33. Walgreens Boots Alliance Inc has a 12 month low of $36.65 and a 12 month high of $64.50.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, April 2nd. The pharmacy operator reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.06. Walgreens Boots Alliance had a return on equity of 21.26% and a net margin of 2.52%. The company had revenue of $35.82 billion for the quarter, compared to analyst estimates of $35.24 billion. During the same period in the prior year, the firm posted $1.64 EPS. Walgreens Boots Alliance’s quarterly revenue was up 3.7% on a year-over-year basis. Sell-side analysts anticipate that Walgreens Boots Alliance Inc will post 5.53 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Wednesday, May 20th will be paid a dividend of $0.4575 per share. The ex-dividend date of this dividend is Tuesday, May 19th. This represents a $1.83 dividend on an annualized basis and a yield of 4.62%. Walgreens Boots Alliance’s payout ratio is 30.55%.

A number of research firms have commented on WBA. UBS Group raised shares of Walgreens Boots Alliance from a “sell” rating to a “neutral” rating and reduced their price objective for the stock from $49.00 to $44.00 in a research report on Monday, April 6th. Deutsche Bank raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating and reduced their target price for the stock from $51.00 to $43.00 in a report on Friday, April 3rd. BidaskClub cut shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Friday, May 15th. SunTrust Banks cut their price objective on shares of Walgreens Boots Alliance from $58.00 to $42.00 and set a “hold” rating for the company in a research report on Friday, April 3rd. Finally, Credit Suisse Group decreased their target price on Walgreens Boots Alliance from $60.00 to $50.00 and set a “neutral” rating on the stock in a research report on Friday, April 3rd. Four equities research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $51.21.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Further Reading: Stop Order

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.